Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells

Cancer stem cells (CSCs) residing in colorectal cancer tissues have tumorigenic capacity and contribute to chemotherapeutic resistance and disease relapse. It is well known that the survival of colorectal CSCs after 5-fluorouracil (5-FU)-based therapy leads to cancer recurrence. Thus CSCs represent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndreshkjana, Benardina, Çapci, Aysun, Klein, Volker, Chanvorachote, Pithi, Muenzner, Julienne K., Huebner, Kerstin, Steinmann, Sara, Erlenbach-Wuensch, Katharina, Geppert, Carol I., Agaimy, Abbas, Ballout, Farah, El-Baba, Chirine, Gali-Muhtasib, Hala, Roehe, Adriana Vial, Hartmann, Arndt, Tsogoeva, Svetlana B., Schneider-Stock, Regine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522523/
https://www.ncbi.nlm.nih.gov/pubmed/31097715
http://dx.doi.org/10.1038/s41419-019-1611-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522523/
https://www.ncbi.nlm.nih.gov/pubmed/31097715
http://dx.doi.org/10.1038/s41419-019-1611-4

Ejemplares similares